from Reuters: Health News https://ift.tt/2UegUvN
ImmunoGen drug fails cancer study, shares slide 40 percent
U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study, driving its shares more than 40 percent lower on Friday.
from Reuters: Health News https://ift.tt/2UegUvN
from Reuters: Health News https://ift.tt/2UegUvN
Subscribe to:
Post Comments (Atom)
-
Sometimes the best paleo snacks are frozen ones. Wether it’s because of hot weather, after a workout or just because you want to feel light ...
-
Let’s be honest: we put our hair through a lot — from heat styling to dye jobs and loading it with product. So, it’s about time our strands...
-
Paleo Grubs Paleo Grubs - She told me that she adds molasses to give it that specific taste. She brought the bottle out for me to dip my ...
No comments:
Post a Comment